The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.

Diabetic retinopathy (DR) is an important cause of avoidable blindness worldwide. Seventy percent of diabetes occur in low and lower-middle income countries. Clinical practice guidelines for the ...

The possible treatment options will depend largely on the type of diabetic retinopathy one has been diagnosed with and its associated severity. Usually, the treatment for this condition is aimed ...

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) today announced updates to the ABBV-RGX-314 clinical program.

Abnormalities of the vitreoretinal interface may contribute to important retinal pathologies such as diabetic ... treatment option currently available is vitrectomy. Pharmacologic treatment ...